Related Experiment Video
Updated: Jan 6, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Picornavirus VP2 protein suppresses innate immunity through selective autophagic degradation of IKBKE/IKKε
Kangli Li1,2, Xiangle Zhang1,2, Dandan Dong1,2
1State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
Abstract:
Senecavirus A (SVA) belongs to the picornaviruses and has emerged as a promising candidate for oncolytic virotherapy in humans. Understanding the immune suppression mechanisms employed by SVA can help optimize its therapeutic efficacy as an oncolytic virus while simultaneously minimizing its immune suppressive effects on normal tissues. In this study, we identified a novel function of the SVA structural protein VP2 as a key viral immune suppressive factor during SVA infection. VP2 targets and degrades IKBKE/IKKε, a key component of the innate immune pathway, thereby suppressing host innate immune responses. It preferentially interacts with the selective autophagic receptor CALCOCO2/NDP52 (calcium binding and coiled-coil domain 2), which then recognizes the K33-linked ubiquitinated IKBKE and delivers it to phagophores for degradation. The E3 ligase RNF114 is responsible for catalyzing the K33-linked ubiquitination of IKBKE at Lys490, and VP2 significantly promoted this modification, which further accelerated IKBKE degradation. Importantly, we found that picornavirus VP2 proteins share this conserved mechanism in degradation of IKBKE and suppression of host innate immunity. These data elucidate the negative regulatory mechanism involving the VP2-RNF114-IKBKE/IKKε-CALCOCO2 axis, and reveal an immune evasion strategy employed by picornaviruses. These findings will provide valuable insights for the development of picornaviral vaccines and antiviral/antitumor therapeutics.Abbreviations: 3-MA: 3-methyladenine; ATG5: autophagy related 5; ATG7: autophagy related 7; CALCOCO2/NDP52: calcium binding and coiled-coil domain 2; CQ: chloroquine; co-IP: co-immunoprecipitation; DAPI: 4',6-diamidino-2'-phenylindole; EV71: enterovirus 71; FMDV: foot-and-mouth disease virus; hpi: hours post-infection; IFN: interferon; IKBKE/IKKε: inhibitor of nuclear factor kappa B kinase subunit epsilon); ISGs: IFN-stimulated genes; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MG132: cbz-leu-leu-leucinal; MOI: multiplicity of infection; NBR1: NBR1 autophagy cargo receptor; OPTN: optineurin; RNF114: ring finger protein 114; RT-PCR: real-time polymerase chain reaction; siRNA: small interfering RNA; SQSTM1/p62: sequestosome 1; SVA: Senecavirus A; TCID50: 50% tissue culture infectious doses. TOLLIP: toll interacting protein; TRIM17: tripartite motif containing 17; TRIM25: tripartite motif containing 25; TRIM28: tripartite motif containing 28; TRIP12/THRI12: thyroid hormone receptor interactor 12; Ub: ubiquitin; Vec: vector; WCL: whole-cell lysate; WT: wild-type.
Insights
Senecavirus A protein VP2 suppresses innate immunity by degrading IKBKE/IKKε via the RNF114-CALCOCO2 pathway. This conserved picornavirus mechanism aids immune evasion and informs oncolytic virus and vaccine development.
Area of Science:
- Virology
- Immunology
- Oncolytic Virotherapy
Background:
- Senecavirus A (SVA) is a picornavirus with potential for oncolytic virotherapy.
- Understanding SVA's immune suppression is crucial for optimizing its therapeutic use.
Purpose of the Study:
- To identify the viral immune suppressive factors of SVA.
- To elucidate the mechanism by which SVA suppresses host innate immunity.
Main Methods:
- Co-immunoprecipitation assays to identify protein interactions.
- Western blotting and RT-PCR to assess protein degradation and gene expression.
- siRNA-mediated knockdown to investigate the roles of specific proteins.
Main Results:
- SVA structural protein VP2 was identified as a key immune suppressive factor.
- VP2 targets IKBKE/IKKε for degradation through interaction with CALCOCO2/NDP52 and promotion of RNF114-mediated ubiquitination.
- This VP2-RNF114-IKBKE/IKKε-CALCOCO2 axis suppresses host innate immune responses.
- The mechanism is conserved among picornaviruses.
Conclusions:
- SVA VP2 employs a novel immune evasion strategy by degrading IKBKE/IKKε.
- This mechanism is conserved across picornaviruses, highlighting a common immune suppression pathway.
- Findings provide insights for developing SVA-based oncolytic viruses, vaccines, and antiviral therapies.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Leaky Scanning
The Antiviral System of Bacteria and Archaea: CRISPR
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

